[1] A.L. Barry, R.N. Jones, Cefixime:spectrum of antibacterial activity against 16,016 clinical isolates, Pediatr. Infect. Dis. 6(10) (1978) 954-957.[2] A. Markham, R.N. Brogden, Cefixime, Drugs 49(6) (1995) 1007-1022.[3] J.S. Pamudji, R. Mauludin, Nurhabibah, influence of β-cyclodextrin on cefixime stability in liquid suspension dosage form, Procedia Chem. 13(2014) 119-127.[4] H.R. Paganini, C.M. Sarkis, M.G.D. Martino, Oral administration of cefixime to lower risk febrile neutropenic children with cancer, Cancer 88(12) (2000) 2848-2852.[5] E. Ghasemian, B. Rezaeian, S. Alaei, Optimization of cefixime nanosuspension to improve drug dissolution, Pharm. Sci. 21(1) (2015) 136-144.[6] B. Pandurang, K. Parven, Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds, US Pat. (2002), 6388070.[7] J. Chen, C.Z. Wang, M. Zhang, Study on the synthesis of cefixime, Chin. J. Antibiot. 37(09) (2012) 687-690.[8] J.S. Pamudji, R. Mauludin, Nurhabibah, Influence of β-cyclodextrin on cefixime stability in liquid suspension dosage form, Procedia Chem. 13(2014) 197-207.[9] E.H.K. Adam, A.E.M. Saeed, I.E. Barakat, Study of degradation of cefixime trihydrate under stress conditions using stability indicating reverse phase-high performance liquid chromatography method, Der Pharma Chem. 3(6) (2011) 105-116.[10] S. Mallick, A. Mondal, S. Sannigrahi, Kinetic measurements of the hydrolytic degradation of cefixime:effect of Captisol complexation and water-soluble polymers, J. Pharm. Pharmacol. 60(7) (2008) 833-841.[11] K. Satoshi, M. Akira, K. Shigetaka, Effect of grinding on the solid-state stability of cefixime trihydrate, Int. J. Pharm. 56(2) (1989) 125-134.[12] National Pharmacopeia Committee, Pharmacopoeia of Peoples Republic of China. Part 2, Chemical Industry Press, Beijing, 2005.[13] M. Li, Organic Chemistry of Drug Degradation, RSC Press, Cambridge, 2012.[14] N. Li, L.S. Taylor, M.G. Ferruzzi, Kinetic study of catechin stability:Effects of pH, concentration, and temperature, J. Agric. Food Chem. 60(51) (2012) 12531-12539.[15] S. Yoshioka, V.J. Stella, Stability of Drugs and Dosage Forms, Springer, Berlin, 2002.[16] D.R. Lide, Handbook of Chemistry and Physics, CRC press, Florida, 2002.[17] J.W. Millard, F.A. Alvarez-Nunez, S.H. Yalkowsky, Solubilization by cosolvents:Establishing useful constants for the log-linear model, Int. J. Pharm. 245(1) (2002) 153-166.[18] P. Zalewski, M. Zajac, A. Jelinska, Stability study of anticancer agent N-[(hexahydroazepin-1-yl) methyl] daunorubicin in aqueous solutions using HPLC method, Asian J. Chem. 23(2) (2011) 835-838.[19] A. Dimitrovska, K. Stojanoski, K. Dorevski, Kinetics of degradation of cefaclor:I. Effects of temperature, phosphate buffer, pH and copper (Ⅱ) ion on the rate of degradation, Int. J. Pharm. 115(2) (1995) 175-182.[20] O. Bekers, J.H. Beijnen, B.J. Vis, Effect of cyclodextrin complexation on the chemical stability of doxorubicin and daunorubicin in aqueous solutions, Int. J. Pharm. 72(2) (1991) 123-130.[21] Z. Przemyslaw, C.P. Judyta, J. Anna, Stability of cefoselis sulfate in aqueous solutions, React. Kinet. Mech. Catal. 108(2) (2013) 285-292.[22] A. Tsuji, E. Nakashima, Y. Deguchi, Degradation kinetics and mechanism of aminocephalosporins in aqueous solution:Cefadroxil, J. Pharm. Sci. 70(10) (1981) 1120-1128.[23] F. Hirayama, M. Kurihara, K. Uekama, Improvement of chemical instability of prostacyclin in aqueous solution by complexation with methylated cyclodextrins, Int. J. Pharm. 35(3) (1987) 193-199.[24] W. Su, S.H. Dong, X. Hu, J.B. Xiao, Y. Chen, Effects of surfactants and polymers on solubilization and solution stability of furacilin, China Pharm. 16(1) (2013) 54-57.[25] Y.Q. Zhang, S.Q. Liu, L.N. Zhang, Effects of various excipients on the stability of perindopril tert-butylamine, Chin. J. Pharm. 6(5) (2008) 288-295.[26] Y. Okamoto, K. Kiriyama, Y. Namiki, Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution. 2. Hydrolytic degradation pathway and mechanism for β-lactam ring opened lactones, J. Pharm. Sci. 85(9) (1996) 976-983.[27] J.M. Indelicato, G.L. Engel, Cephalothin:hydrolysis of the C-3'-acetoxy moiety of a 7-aminocephalosporanic acid; observation of both acyl-oxygen bond cleavage and reversible alkyl-oxygen bond cleavage, J. Pharm. Sci. 74(11) (1985) 1162-1166.[28] H. Fabre, N.H. Eddine, G. Berge, Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin, J. Pharm. Sci. 73(5) (1984) 611-618.[29] D.B. Boyd, W.H.W. Lunn, Electronic structures of cephalosporins and penicillins. 9. Departure of a leaving group in cephalosporins, J. Med. Chem. 22(22) (1979) 778-784.[30] S.W. Baertschi, D.E. Dorman, J.L. Occolowitz, Isolation and structure elucidation of the major degradation products of cefaclor formed under aqueous acidic conditions, J. Pharm. Sci. 86(5) (1997) 526-539.[31] Y. Okamoto, K. Kiriyama, Y. Namiki, Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution, J. Pharm. Sci. 85(9) (1996) 976-983.[32] European Pharmacopoeia 6.0., EDQM Press, Europe, 2007.[33] L. Bian, M. Song, T.J. Hang, Identification of the related substances in cefixime by LCMS/MS with acetonitrile aided electrospray ionization, Chin. J. Pharm. Anal. 30(5) (2010) 872-878.[34] Z. Talebpour, H. Pourabdollahi, H. Rafati, Determination of cefixime by a validated stability-indicating HPLC method and identification of its related substances by LC-MS/MS studies, Sci. Pharm. 81(2) (2013) 493-503. |